Fewer Black Queer People are Taking PrEP. Meet the Students Fighting to Change That.
These young people have the tools necessary to link their peers with resources to access PrEP medications.
September 27 2023 2:30 PM
By continuing to use our site, you agree to our Private Policy and Terms of Use.
These young people have the tools necessary to link their peers with resources to access PrEP medications.
White Republicans have targeted PrEP access in an attempt to limit what insurance companies cover, Democrats are trying to expand access to the life saving drugs.
Lawyers for both sides agreed to a compromise while the case on prevenantive health care coverage makes its way through the appeals process.
The court issued a stay that will last for the duration of the government’s appeal in the case.
The agency has moved toward risk-based assessments as opposed to discriminatory bans based on gender or sexual orientation.
Government regulators are seeking public comment for its new national coverage analysis for PrEP.
U.S. District Judge Reed O'Connor ruled Wednesday that requiring insurance companies to cover medications to prevent HIV transmission violates plaintiffs' rights on religious grounds.
Jonathan Mitchell, the Texas attorney challenging PrEP access, said the named plaintiff is being threatened and bullied.
PrEP drugs "encourage and facilitate homosexual behavior," says Texas abortion law author Jonathan Mitchell in a federal lawsuit targeting the antiviral medications.
Gov. Jared Polis signed the bills into law Monday, along with one making it easier for minors to change the gender on their birth certificates.
Officials encourage a new non-daily PrEP strategy for those at lower risk for contracting HIV.
The British government aims to end HIV transmissions in the country by 2030.
The HIV-prevention method has been credited with a remarkable drop in transmissions.
The activist group wants the federal government to reject a patent extension for Gilead's tenofovir alafenamide, a component of several HIV meds.
The federal government today announced the procedure for applying for free HIV prevention drugs.
The maker of Truvada and Descovy has not ever paid licensing frees for PrEP, a patented process discovered by scientists at the CDC.